BioPharma Drug Discovery
Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company and Ubix Therapeutics (en.ubixtrx.com), a South Korea-based biotech co...
June 17, 2021 | News
The Novavax trials conducted on 29,960 people in the US and Mexico have delivered results that equal the Pfizer NSE -1.09 % and Moderna jabs and do better ...
June 16, 2021 | News
Harbour BioMed scientists and Dana-Farber researchers will be working together to develop novel oncologic drugs, including bispecific antibodies and CAR-T ...
June 16, 2021 | News
93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against...
June 15, 2021 | News
The collaboration will leverage both the advantages of VERAXA's advanced and proprietary position-true click-chemistry-based drug conjugation technology in...
June 14, 2021 | News
The agency is announcing today that it is authorizing for use, under the emergency use authorization (EUA) for the Janssen COVID-19 vaccine, two batches of...
June 12, 2021 | News
Leading academic, research and industry group led by Broad Institute to help speed drug discovery PerkinElmer, Inc., a global leader committed to ...
June 11, 2021 | News
This approval is significant in many ways. Aduhelm is the first novel therapy approved for Alzheimer’s disease since 2003. Perhaps more significantly...
June 09, 2021 | News | By Dr. Patrizia Cavazzoni, Director, FDA Center for Drug Evaluation and Research
First-Time Disease-Free Survival Data to be Presented During Plenary Session at the 2021 ASCO Annual Meeting Merck’s KEYTRUDA® (pemb...
June 07, 2021 | News
ASCO 2021, which celebrates its 57th anniversary this year, runs from June 4th to June 8th and will be held virtually due to COVID-19. Some ...
June 07, 2021 | News
By leveraging the proprietary technology platform built for drug discovery and screening, MicuRx R&D team discovered the next-generation oxazolidinone ...
June 04, 2021 | News
TLC (Nasdaq: TLC, TWO: 4152), a clinical‐stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, and...
June 02, 2021 | News
Also known as chronic yeast infection, RVVC is a debilitating infectious condition defined as three or more episodes per year. Although RVVC affects nearly...
June 02, 2021 | News
The drug Kin.001 is at the beginning of the clinical trial phase and will be on the market at the end of 2022, said CEO Alexander Bausch in a video report ...
June 02, 2021 | News
Most Read
Bio Jobs
News
Editor Picks